UPDATE: Benchmark Company Reiterates Buy Rating, Lowers PT on Analogic Corporation
In a report published Wednesday, Benchmark Company reiterated its Buy rating on Analogic Corporation (NASDAQ: ALOG), but lowered its price target from $90.00 to $87.00.
Benchmark Company noted, “We are transitioning coverage of ALOG from the Defense & Homeland Security industry to the Medical Device industry. We believe that this transition better represents ALOG's business model, as 88% of ALOG's fiscal 2012 revenue was driven by their Medical Imaging and Ultrasound business while 12% of ALOG's revenue was driven by Security Technology.”
Analogic Corporation closed on Tuesday at $73.07.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.